Garassino, M., Gadgeel, S., Speranza, G., Felip, E., Esteban, E., Dómine, M., . . . Rodríguez-Abreu, D. (2023). Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer: 5-year outcomes from the phase 3 KEYNOTE-189 study. Journal of clinical oncology, 41(11), . https://doi.org/10.1200/JCO.22.01989
Chicago-Zitierstil (17. Ausg.)Garassino, Marina, et al. "Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-small-cell Lung Cancer: 5-year Outcomes from the Phase 3 KEYNOTE-189 Study." Journal of Clinical Oncology 41, no. 11 (2023). https://doi.org/10.1200/JCO.22.01989.
MLA-Zitierstil (9. Ausg.)Garassino, Marina, et al. "Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-small-cell Lung Cancer: 5-year Outcomes from the Phase 3 KEYNOTE-189 Study." Journal of Clinical Oncology, vol. 41, no. 11, 2023, https://doi.org/10.1200/JCO.22.01989.